Pneumovax 23 Patient Assistance Program
Don’t let the high cost of brand 23-valent pneumococcal polysaccharide vaccine disrupt your adult immunization. We help eligible patients access Pneumovax 23 (pneumococcal polysaccharide vaccine 23-valent) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
Key Takeaways:
- Pneumovax 23 (PPSV23 — pneumococcal polysaccharide vaccine 23-valent) is FDA-approved for prevention of pneumococcal disease in adults 50 years and older and persons 2 years and older at increased risk. Historical adult pneumococcal vaccine covering 23 pneumococcal serotypes. Given after PCV15 (Vaxneuvance) in current ACIP recommendation, or as historical adult vaccination — but PCV20 or PCV21 (Capvaxive) single-dose options now available.
- Without assistance, Pneumovax 23 costs commonly run approximately $100–$150 per dose.
- Through AffordMyPrescriptions, qualifying patients can access Pneumovax 23 for a flat $69.95 per month.
- Modern pneumococcal vaccine landscape: PCV13 (Prevnar 13 — historical), PCV15 (Vaxneuvance — brand), PCV20 (Prevnar 20 — brand), PCV21 (Capvaxive — brand, adult-focused serotypes), PPSV23 (Pneumovax 23 — polysaccharide). Current ACIP 2024 recommendation for adults 50+: one dose of PCV20 or PCV21, OR PCV15 followed by PPSV23. Under ACA and IRA Medicare Part D, ACIP-recommended vaccines covered without cost-sharing. Multiple options simplify adult pneumococcal vaccination.
What is Pneumovax 23 Prescription Assistance Program?
The Pneumovax 23 Patient Assistance Program helps eligible patients access this pneumococcal polysaccharide vaccine at little or no cost when meeting income, insurance, and clinical criteria. Under ACA, most privately insured have vaccine coverage without cost-sharing.
At AffordMyPrescriptions, our Patient Advocates handle the entire Pneumovax 23 PAP enrollment for a flat $69.95 per month — so you never face a gap in your pneumococcal immunization.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your Pneumovax 23 enrollment — so you never face a gap in your pneumococcal disease prevention.
Pharmacy Price Comparison
- Without assistance, Pneumovax 23 costs around a hundred dollars per dose. A Patient Assistance Program can offset costs if you qualify:
| PHARMACY | PRICE (30-DAY) WITH BEST COUPONS | YOU SAVE W/ US |
|---|---|---|
| ACA / Medicare $0 vaccine | $0 | ACA / IRA covered |
| Walgreens | ~$140/dose | Save substantially |
| CVS Pharmacy | ~$150/dose | Save substantially |
| Walmart | ~$110/dose | Save substantially |
| Costco | ~$100/dose | Save substantially |
| Vaxneuvance (PCV15 alt) | ~$240/dose | Alt PCV15 conjugate |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. AffordMyPrescriptions Advocacy Service bypasses pharmacy pricing entirely by using the manufacturer’s assistance program to secure your Pneumovax 23 — independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Pneumovax 23 Prescription Program?
The Pneumovax 23 Patient Assistance Program is free to apply. Our $69.95 per month covers full advocacy. Under ACA and IRA Medicare Part D, ACIP-recommended vaccines are covered without cost-sharing. Modern pneumococcal vaccine landscape allows single-dose PCV20 or PCV21 as alternative to Pneumovax 23 sequential regimen.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for Pneumovax 23 assistance.
We Advocate
Our specialists gather documentation, complete applications, and coordinate with your prescriber and the assistance program.
Receive Medication
Once approved, your Pneumovax 23 is delivered through the assistance program while we manage refills and annual renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Pneumovax 23:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $100–$150/dose per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
If denied, we explore alternative savings paths on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Pneumovax 23 assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Pneumovax 23 Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Pneumovax 23:
Pneumovax 23 (PPSV23) is a 23-valent pneumococcal polysaccharide vaccine — historical adult pneumococcal vaccine. Covers 23 pneumococcal serotypes but with less durable immunity than conjugate vaccines. Given after PCV15 (Vaxneuvance) in current ACIP recommendation; alternatively single-dose PCV20 or PCV21 (Capvaxive) can be used.
How It Works:
Streptococcus pneumoniae (pneumococcus) causes pneumonia, meningitis, sepsis, and other invasive disease. Adults 65+ and adults with certain medical conditions have highest disease risk. Historical adult pneumococcal vaccination used PPSV23 (Pneumovax 23) alone or in sequence with conjugate vaccines. Pneumovax 23 (PPSV23) is a polysaccharide vaccine — direct pneumococcal capsular polysaccharides for 23 serotypes elicit antibody response. Broader serotype coverage than early conjugate vaccines but T-cell-independent response with less durable immunity and memory. Modern conjugate vaccines (PCV13, PCV15, PCV20, PCV21) provide T-cell-dependent responses with durable protection. Current ACIP 2024 recommendation for adults 50+: one dose of PCV20 or PCV21 (Capvaxive), OR PCV15 (Vaxneuvance) followed 1+ year later by PPSV23 (Pneumovax 23). Additional considerations for immunocompromised or high-risk conditions.
Form and Use:
Pneumovax 23 0.5 mL IM or SC injection in deltoid. Timing depends on ACIP recommendation and prior vaccination history. Given at pharmacy, clinic, or occupational health.
Generic Availability:
No generic Pneumovax 23. Modern pneumococcal vaccine landscape (all brand): PCV15 (Vaxneuvance), PCV20 (Prevnar 20), PCV21 (Capvaxive — 21-valent adult-focused serotypes). ACIP 2024: adults 50+ receive one dose of PCV20 or PCV21, OR Vaxneuvance (PCV15) followed by Pneumovax 23. Under ACA and IRA Medicare Part D, ACIP-recommended vaccines covered without cost-sharing. Merck Vaccine Patient Assistance Program for uninsured. State/local health departments. CDC and ACIP resources.
Warnings:
Anaphylaxis and severe allergic reactions (rare — do not administer to persons with severe allergic reaction to prior pneumococcal vaccine or component), embryo-fetal considerations (safety in pregnancy not fully established — weigh risk-benefit), immunocompromised (may have reduced immune response). Other: injection site pain, redness, swelling; fatigue, headache, myalgia, low-grade fever. Not a live vaccine — safe for immunocompromised from a live-vaccine standpoint. Moderately potent local reactions in some — particularly with revaccination close to prior dose.
FAQ (Frequently Asked Questions)
How much does Pneumovax 23 cost without insurance?
$100–$150 per dose at pharmacies. Under ACA, ACIP-recommended vaccines covered without cost-sharing for privately insured. IRA — Medicare Part D covers adult vaccines at $0 (2023). Verify with insurance.
How is Pneumovax 23 different from PCV20 (Prevnar 20) or PCV21 (Capvaxive)?
Pneumovax 23 is a polysaccharide vaccine (PPSV23) — direct polysaccharides for 23 serotypes; broader serotype coverage historically but less durable immunity. PCV20 and PCV21 are conjugate vaccines — polysaccharides linked to carrier protein for T-cell-dependent durable response. Current ACIP 2024 recommendation for adults 50+: one dose of PCV20 or PCV21 (Capvaxive), OR PCV15 followed 1+ year later by PPSV23 (Pneumovax 23). Single-dose PCV20/PCV21 simpler regimen.
Who should get Pneumovax 23?
In current ACIP guidance (2024), adults 50+ receiving PCV15 (Vaxneuvance) should receive PPSV23 (Pneumovax 23) 1+ year later. Alternative: single dose of PCV20 or PCV21 (Capvaxive) — no PPSV23 needed. Adults with certain immunocompromising conditions may need additional PPSV23 dose per ACIP. Discuss with primary care.
Do I need Pneumovax 23 if I already got Prevnar 20 or Capvaxive?
Generally no. Current ACIP 2024 recommendation: PCV20 or PCV21 (Capvaxive) alone is sufficient for most adults 50+ — no additional PPSV23 needed. If you received PCV15 (Vaxneuvance) instead, PPSV23 (Pneumovax 23) should follow. Discuss with primary care based on your specific vaccination history.
How is Pneumovax 23 given?
IM or SC injection in deltoid. Given at pharmacy, clinic, or provider office. Under ACA and IRA Medicare Part D, most adults have $0 cost-share for ACIP-recommended vaccines.
Take Control of Your Medication Costs
Adult pneumococcal vaccination prevents serious pneumonia and invasive disease. Our advocacy team is ready — $69.95 per month, or free if we cannot help.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.